Natsuki Furukawa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Top Venues

Expert opinion on therapeutic targets

Cell death discovery

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Wendy Yang, Alex R Chao, Akash Patil, Adam C Mirando, Niranjan B Pandey, Aleksander S Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Cell death discovery 10 (1) (2024)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets (2023)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets 26 (12) (2023)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets 26 (12) (2023)
Natsuki Furukawa, Wendy Yang, Alex Chao, Akash Patil, Adam Mirando, Niranjan Pandey, Aleksander Popel
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth. Research square (2023)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets 26 (12) (2023)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: Shedding light on mechanisms and targeting. Expert opinion on therapeutic targets (2023)
Natsuki Furukawa, Vered Stearns, Cesar A Santa-Maria, Aleksander S Popel
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets 26 (12) (2023)